Preventing group B streptococcal infection in newborns.
Where this comes from
- Record sourced from PubMed, PMID 1990734.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Group B streptococci, commonly found in the maternal gastrointestinal and genitourinary tracts, can be transmitted to the neonate at the time of rupture of membranes and during delivery. Current management strategies include early detection of group B streptococcal carriers and the administration of intrapartum prophylactic antibiotics to prevent maternal fetal transmission. Several tests are now available to rapidly identify group B streptococcal carriers. Physicians should be able to recognize patients at high risk for colonization and the situations in which prophylactic antibiotics should be employed. Proper use of antibiotics during labor can eliminate group B streptococcal sepsis in neonates. Early group B streptococcal meningitis carries a mortality rate of almost 50 percent, despite medical support from neonatal intensive care units.